Accessibility Menu

Rua Life Sciences Plc(LSE) AOR

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-98%
5 Year-78%
1 Year+127%
1 Month+8%
N/A
Rua Life Sciences Plc last closing stock price
MetricPriceDate
Last closeGBX 27.502026-08-28
Rua Life Sciences Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.77%GBX 26.002026-08-21
1 month+7.84%GBX 25.502026-07-29
3 month+37.5%GBX 20.002026-05-29
Year to date+96.43%GBX 14.002025-12-31
1 year+126.71%GBX 12.132025-08-28
3 year+46.67%GBX 18.752023-08-29
5 year-78.35%GBX 127.002021-08-27
Since inception-97.81%GBX 12.571997-02-26

Rua Life Sciences Plc Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

AOR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rua Life Sciences Plc

RUA Life Sciences Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. It manufactures biostable and implantable polymers under the Elast-Eon and ECSil brands. The company was founded by James Gordon Wright and Edward McDaid in 1992 and is headquartered in Ayrshire, the United Kingdom.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Bill Brown

Website

www.aortech.com

AOR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Rua Life Sciences Plc Performance Analysis

Rua Life Sciences Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 2,179,00034.1%
20242024-03-31USD 2,191,0000.6%
20252025-03-31USD 4,113,00087.7%
20252025-09-30USD 4,459,35687.7%
Rua Life Sciences Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.09-3.1%
20242024-03-31USD -0.04-52.5%
20252025-03-31USD 0.00N/A
20252025-09-30USD -0.00N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About AOR

What is the current price of Rua Life Sciences Plc?

Rua Life Sciences Plc is trading at N/A per share.

What is the 52-week range for Rua Life Sciences Plc?

Over the past 52 weeks, Rua Life Sciences Plc has traded between N/A and N/A.

How much debt does Rua Life Sciences Plc have?

As of the most recent reporting period, Rua Life Sciences Plc reported total debt of $794.00K.

How much cash does Rua Life Sciences Plc have on hand?

Rua Life Sciences Plc reported $3.25M in cash and cash equivalents in its most recent financial results.

What is Rua Life Sciences Plc’s dividend yield?

Rua Life Sciences Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services